Clinical Trial Update: The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy, tolerability, and safety of donepezil (Aricept) in patients with Parkinson's disease dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Dementia

Drugs mentioned

• Donepezil (Aricept) (Donepezil)

Snippet

Sponsor: Eisai Limited | Conditions: Dementia With Parkinson's Disease | Phase 3 | Status: COMPLETED